Hacettepe University
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Hacettepe University
Jun 26, 2024, 06:07 |
Insight
Prognostic significance of Pan-Immune-Inflammation value in mBC treated with Trastuzumab Emtansine
Taha Koray Sahin, Medical Oncologist at Hacettepe University Hospitals, shared on X: “I am excited to…
Jun 11, 2024, 09:50 |
Blog
Pervin Hurmuz: Our new paper about the role of definitive Radiotherapy for cN+ Prostate Cancer
Pervin Hurmuz, Professor at Hacettepe University Faculty of Medicine, Department of Radiation Oncology, shared on X/Twitter:…
May 13, 2024, 15:05 |
Blog
Taha Koray Sahin: Promising tool for real-world patient care
Taha Koray Sahin, Medical Oncologist at Hacettepe University, shared on X/Twitter: "I am thrilled to share…
Oct 24, 2023, 15:29 |
Blog
Deniz Can Guven: We got the best poster award for palliative care
Deniz Can Guven, Medical Oncologist at Health Sciences University, recently shared on X/Twitter: "ESMO2023 excitement is…
All:
4
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube